Replies to post #178220 on Biotech Values

[DewDiligence]

PVCT, which has only four employees (according to Yahoo Finance), still sports a (fully-diluted) enterprise value of >$500M, although that’s down from $1B+ in Jan 2014 (#msg-96287931).

The company had a CC Friday afternoon to discuss the FDA’s denial of BTD for the company’s lead drug, PV-10:
http://finance.yahoo.com/news/provectus-biopharmaceuticals-inc-reaffirms-commitment-175300043.html

Earlier last week, PVCT issued to PR to “rebut” a Seeking Alpha piece claiming (among other things) that PV-10 would be denied BTD:
http://finance.yahoo.com/news/provectus-biopharmaceuticals-inc-refutes-inaccuracies-180800786.html

All told, PVCT looks like a great stock to avoid (unless you can short it).